ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
145 hedge funds and large institutions have $460M invested in iTeos Therapeutics in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 47 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 152 → 145 (-7)
6% less capital invested
Capital invested by funds: $489M → $460M (-$28.4M)
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
Holders
145
Holding in Top 10
2
Calls
$1.38M
Puts
$1.01M
Top Buyers
| 1 | +$3.94M | |
| 2 | +$3.1M | |
| 3 | +$2.87M | |
| 4 |
Goldman Sachs
New York
|
+$2.72M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.16M |
Top Sellers
| 1 | -$6.7M | |
| 2 | -$5.12M | |
| 3 | -$4.94M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.47M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.29M |